HPF1 Activators
Common HPF1 Activators include, but are not limited to Olaparib CAS 763113-22-0, Suberoylanilide Hydroxamic Acid CAS 149647-78-9, Belinostat CAS 414864-00-9, Panobinostat CAS 404950-80-7 and MS-275 CAS 209783-80-2.
HPF1, short for Histone PARylation Factor 1, is a protein that has attracted attention within the scientific community due to its association with the regulation of ADP-ribosylation, a post-translational modification of proteins. ADP-ribosylation has been recognized as playing pivotal roles in various cellular processes, including DNA repair, transcription, and cell signaling. HPF1 has been identified as a critical factor that modulates the activity of PARP1 and PARP2, enzymes known for their involvement in DNA repair mechanisms, especially in response to DNA damage. By interacting with these enzymes, HPF1 directs ADP-ribosylation towards serine residues on target proteins.
HPF1 activators encompasses chemical compounds that can enhance the activity or expression of HPF1. By doing so, these activators may indirectly influence the efficiency of the ADP-ribosylation process and, consequently, the DNA repair mechanisms mediated by PARP1 and PARP2. Given the intricate nature of cellular mechanisms, the modulation of a single protein's activity can have cascading effects on various interconnected pathways. While the primary focus of HPF1 activators is the upregulation of HPF1, it's essential to consider the broader network of interactions and the potential consequences of altering the balance within this network. As with many chemical activators, understanding the specificity, potency, and mechanism of action is paramount, ensuring that the desired cellular outcome is achieved without undesired off-target effects. As the field of HPF1 research evolves, the development and understanding of HPF1 activators will likely expand, offering deeper insights into the complex world of protein modulation and its effects on cellular dynamics.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
By inhibiting PARP-1, Olaparib might disrupt the interaction between PARP-1 and HPF1, potentially leading to a compensatory upregulation of HPF1 expression to maintain DNA repair processes. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Similar to Olaparib, Rucaparib might potentially influence HPF1 expression through modulating PARP-1 activity, possibly triggering a compensatory response to uphold DNA damage response efficiency. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
By inhibiting PARP-1, Niraparib might potentially induce a compensatory upregulation of HPF1 expression to ensure effective DNA damage response. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
Similar to other PARP inhibitors, Talazoparib might potentially trigger a compensatory upregulation of HPF1 expression to maintain DNA repair processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
By inhibiting histone deacetylases and affecting chromatin organization, Vorinostat might potentially create a cellular environment that induces HPF1 expression to regulate chromatin structure or DNA repair processes. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat might potentially influence HPF1 expression through modulating chromatin organization, possibly triggering HPF1 expression to maintain or restore normal chromatin structure. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
By affecting chromatin structure, Panobinostat might potentially induce HPF1 expression as a compensatory response to ensure effective DNA damage response or chromatin regulation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Similar to other HDAC inhibitors, Entinostat might potentially induce HPF1 expression by affecting chromatin organization and DNA repair pathway dynamics. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
By inducing DNA damage, Etoposide might potentially trigger a cellular response that includes upregulation of HPF1 expression to effectively address DNA lesions. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin might potentially induce DNA damage, leading to a cellular response that could include upregulation of HPF1 expression to aid in DNA repair processes. | ||||||